📊 PEPG Key Takeaways
Is PepGen Inc. (PEPG) a Good Investment?
PepGen is a pre-revenue pharmaceutical company burning approximately $18.4M annually with no clear path to profitability. Despite a solid balance sheet with zero debt and $42.1M in cash (providing ~2+ years runway), the absence of revenue generation, persistent operating losses, and typical biotech execution risk present material downside. The modest improvement in loss trajectory is insufficient to offset the fundamental lack of commercial traction.
PepGen Inc. Key Strengths (PEPG)
- Strong balance sheet with zero debt and $134M stockholders' equity
- Excellent liquidity position with 14.98x current ratio and $42.1M cash reserves
- Improving loss profile with 25.6% YoY improvement in diluted EPS
PEPG Stock Risks: PepGen Inc. Investment Risks
- No revenue generation indicating pre-commercial stage with high development risk
- Significant operating cash burn of $18.4M annually with limited profitability visibility
- Typical biotech execution and pipeline risk with uncertain clinical success rates
- Constrained cash runway despite adequate current position without revenue inflection
Key Metrics to Watch
- Operating cash burn rate and remaining cash runway
- Clinical development milestones and regulatory approval progress
- Timeline to first commercial revenue and addressable market size
- Insider trading activity frequency and transaction direction
PepGen Inc. (PEPG) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 14.98x current ratio provides a solid financial cushion.
PEPG Profit Margin, ROE & Profitability Analysis
PEPG vs Healthcare Sector: How PepGen Inc. Compares
How PepGen Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is PepGen Inc. Stock Overvalued? PEPG Valuation Analysis 2026
Based on fundamental analysis, PepGen Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
PepGen Inc. Balance Sheet: PEPG Debt, Cash & Liquidity
PEPG Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: PepGen Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-2.85 indicates the company is currently unprofitable.
PEPG Revenue Growth, EPS Growth & YoY Performance
PepGen Inc. Dividends, Buybacks & Capital Allocation
PEPG SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for PepGen Inc. (CIK: 0001835597)
📋 Recent SEC Filings
❓ Frequently Asked Questions about PEPG
What is the AI rating for PEPG?
PepGen Inc. (PEPG) has an AI grade of C with 68% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PEPG's key strengths?
Claude: Strong balance sheet with zero debt and $134M stockholders' equity. Excellent liquidity position with 14.98x current ratio and $42.1M cash reserves.
What are the risks of investing in PEPG?
Claude: No revenue generation indicating pre-commercial stage with high development risk. Significant operating cash burn of $18.4M annually with limited profitability visibility.
What is PEPG's revenue and growth?
PepGen Inc. reported revenue of N/A.
Does PEPG pay dividends?
PepGen Inc. does not currently pay dividends.
Where can I find PEPG SEC filings?
Official SEC filings for PepGen Inc. (CIK: 0001835597) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PEPG's EPS?
PepGen Inc. has a diluted EPS of $-0.26.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is PEPG's fundamental grade?
Based on our AI fundamental analysis in May 2026, PepGen Inc. has a C grade with 68% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is PEPG stock overvalued or undervalued?
Valuation metrics for PEPG: ROE of -13.3% (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is PEPG's AI grade for 2026?
Our dual AI analysis gives PepGen Inc. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PEPG's free cash flow?
PepGen Inc.'s operating cash flow is $-18.4M, with capital expenditures of $0.0.
How does PEPG compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE -13.3% (avg: 15%), current ratio 14.98 (avg: 2).